long-term efficacy of pembrolizumab in advanced melanoma
Published 7 years ago • 761 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:23
3-year update shows continued efficacy of pembrolizumab for melanoma
-
1:53
dr. eggermont discusses impact of pembrolizumab in melanoma
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
3:25
metastatic melanoma: long-term benefits of a targeted therapies combination
-
2:21
when should treatment be stopped?
-
1:11
looking back on the first immune checkpoint inhibitor approved in melanoma
-
5:40
immunotherapy and targeted therapies for melanoma
-
1:33
dr. robert on next steps following the phase iii combi-v study in melanoma
-
1:26
metastatic melanoma: the checkmate 067 and 069 trials
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
1:12
investigators present updated results of the opacin trial for melanoma
-
10:42
what is new in melanoma?
-
6:31
how to choose first line therapy in melanoma?
-
1:12
exploring treatment options for patients with advanced melanoma
-
1:32
dr. liebman on toxicities of braf inhibitors in melanoma
-
47:20
melanoma immunotherapy: what's next for patients? with antoni ribas
-
8:35
long-term results for immunotherapy in melanoma
-
7:44
caroline robert, gustave roussy, villejuif, france:
-
3:03
what's the best option in the treatment of melanoma?